Japan industry group to examine clinical site cost discrepancies

By Gareth Macdonald

- Last updated on GMT

© Getty Images / itasun
© Getty Images / itasun

Related tags Clinical trial

Japanese industry group JPMA has opted for cloud-based tech to help it understand why the cost of running a trial in the country varies depending on the site involved.

The Japan Pharmaceutical Manufacturers Association (JPMA) announced the project today, explaining that it will use Medidata software to model site-to-site cost variation and compare the findings with data from the UK, the US and 17 Asia-Pacific countries.

The collaboration follows a JPMA report (here​ in Japanese) highlighting the various cost calculations and payment methods in use at different investigator sites, which it suggests are holding back drug development in the country.

Shingo Haseto, leader of the JPMA’s clinical evaluation taskforce, said: “As the Japanese clinical trial landscape evolves, it is increasingly important that we ensure consistent and fair payment—both for sponsors and sites.”

He added that a better understanding of the cost discrepancies will result in “increased transparency around clinical trial costs related to site performance.”


Japan has its own good clinical practice standard – J-GCP – which while similar to International Conference on Harmonisation GCP standards (ICH-GCP) differ in some key respects​.

The key differences – as they apply to trial sites in Japan – is the requirement that, in most cases, sites have their own institutional review board and the rule that site heads are responsible for signing all financial contracts.

Related news

Show more

Related products

show more

Are You Prepared to Meet the New FDA Guidelines?

Are You Prepared to Meet the New FDA Guidelines?

Elligo Health Research® | 23-Mar-2023 | Insight Guide

On April 15, 2022, the U.S. Food and Drug Administration issued a new draft guidance to clinical research sponsors on creating a plan to enroll more participants...

ODM and CDASH in CRF design

ODM and CDASH in CRF design

Formedix | 10-Mar-2023 | Technical / White Paper

The lesser-known Operational Data Model (ODM) standard is often overlooked as it's not required by any regulators. So, why should you be interested...

4 Warning Signs Your Research Site Is in Trouble

4 Warning Signs Your Research Site Is in Trouble

Elligo Health Research® | 10-Mar-2023 | Insight Guide

You want your clinical research practice to be a success for your business and your patients, but how can you tell if it’s in trouble? Read this article...

How Sponsors Reduce Chaos in Decentralized Trials

How Sponsors Reduce Chaos in Decentralized Trials

Florence Healthcare | 08-Mar-2023 | Insight Guide

89% of research sponsors currently use and expect to continue the use of decentralized technologies and methods, according to our state of the industry...

Related suppliers

Follow us


View more